Mechanistically, MALAT1 interacts with EZH2 protein to suppress the expression of E-cadherin, up-regulate the expression of β-catenin and induce epithelial-mesenchymal transition, and MALAT1 silencing reduces RCC cell proliferation, invasion and metastasis [9]. Here, EZH2 is linked to renal cell carcinoma.